Copper-Loaded Nanoheterojunction Enables Superb Orthotopic Osteosarcoma Therapy via Oxidative Stress and Cell Cuproptosis

Jiechao Xia,Chuan Hu,Yinwen Ji,Min Wang,Yang Jin,Lin Ye,Dingqi Xie,Sicheng Jiang,Renhong Li,Zhijun Hu,Jiayong Dai

DOI: https://doi.org/10.1021/acsnano.3c04903

IF: 17.1

2023-10-30

ACS Nano

Abstract:Catalytic tumor therapy based on two-dimensional (2D) nanomaterials is a burgeoning and promising tumor therapeutic modality. However, the inefficient utilization and conversion of exogenous stimulation, single catalytic modality, and unsatisfactory therapeutic efficiency in the tumor microenvironment (TME) have seriously restricted their further application in tumor therapy. Herein, the heterogeneous carbon nitride-based nanoagent named T-HCN@CuMS was successfully developed, which dramatically improved the efficiency of the tumor therapeutic modality. Benefiting from the donor-acceptor (triazine-heptazine) structure within the heterogeneous carbon nitride nanosheets (HCN) and the construction of interplanar heterostructure with copper loaded metallic molybdenum bisulfide nanosheets (CuMS), T-HCN@CuMS presented a favorable photo-induced catalytic property to generate abundant reactive oxygen species (ROS) under near-infrared (NIR) light irradiation. Besides, the choice of CuMS simultaneously enabled this nanoagent to efficiently catalyze the Fenton-like reaction and trigger cell cuproptosis, a recently recognized regulated cell death mode characterized by imbalanced intracellular copper homeostasis and aggregation of lipoylated mitochondrial proteins. Moreover, upon surface modification with cRGD_fk-PEG_2k-DSPE, T-HCN@CuMS was prepared and endowed with improved dispersibility and α_vβ₃ integrins targeting ability. In general, through the rational design, T-HCN@CuMS was facilely prepared and had achieved satisfactory antitumor and antimetastasis outcomes both <i>in vitro</i> and in a high-metastatic orthotopic osteosarcoma model. This strategy could offer an idea to treat malignant diseases based on 2D nanomaterials.

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology

What problem does this paper attempt to address?

The paper mainly aims to address the following issues:

1. **Improving tumor treatment efficacy**: Existing catalytic tumor treatment methods based on two-dimensional (2D) nanomaterials have some limitations, including low utilization efficiency of exogenous stimuli, single catalytic mode, and suboptimal therapeutic effects in the tumor microenvironment (TME).

2. **Enhancing the efficiency of catalytic therapy**: By constructing a novel nanoheterojunction, the goal is to improve the efficiency of catalytic therapy, especially for highly malignant tumors like osteosarcoma.

3. **Developing efficient osteosarcoma treatment methods**: Osteosarcoma is one of the most common primary malignant bone tumors, with a high incidence in adolescents and young adults. Currently, surgery combined with adjuvant chemotherapy is the mainstream treatment method, but for patients with metastatic disease, the event-free survival rate is less than 30%. Therefore, more effective treatment methods need to be developed.

To address the above issues, the research team developed a heterostructured carbon nitride-based nanomedicine named T-HCN@CuMS. This nanomedicine is achieved by constructing heterostructured carbon nitride nanosheets (HCN) containing copper-loaded metal molybdenum sulfide nanosheets (CuMS). Specifically, by constructing the interfacial heterostructure between HCN and CuMS, the ability to generate reactive oxygen species (ROS) under near-infrared irradiation is enhanced, and it can trigger cuproptosis, a regulated cell death mode caused by intracellular copper homeostasis imbalance and aggregation of fatty acylated mitochondrial proteins. Additionally, by surface modification with cRGDfk-PEG2k-DSPE, the dispersibility of the nanomedicine and its targeting ability to αvβ3 integrin are enhanced, thereby achieving effective anti-tumor and anti-metastasis effects in vitro and in vivo in highly metastatic osteosarcoma models. This approach provides a new perspective for the treatment of malignant diseases based on 2D nanomaterials.